Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity. - Wassarman, Douglas R.; Pfaff, Patrick; Paulo, Joao A.; Gygi, Steven P.; Shokat, Kevan M.; Kranzusch, Philip J. (Science, 2025)